s6y
Company name or ticker
Search
Vivo Capital Surplus Fund VIII, L.P.
3
Crinetics Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
Filed
Tuesday, July 17, 2018
Period
Jul 17, 2018
Accession number
0001615774-18-006600
Documents
3
3
On sec.gov
Filing index
All files
Complete submission text
SGML header